2022 Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

Co-sponsored by the American Association for the Study of Liver Diseases (AASLD)

This guideline provides evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other stakeholders.

Read Guideline


AACE Podcasts Episode 31:

Listen to endocrine expert Vin Tangpricha, M.D., Ph.D., as he interviews AACE Co-Chairs, guideline task force experts, Kenneth Cusi, MD, FACP, FACE, and Scott D. Isaacs, MD, FACP, FACE, about the newly released 2022 clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease, published in the May 2022 issue of Endocrine Practice.


AACE Podcast Episode 38:

Listen to endocrine experts Betul Hatipoglu MD, Professor of Medicine at CWRU School of Medicine, and Medical Director for Diabetes & Obesity Center at University Hospital Cleveland Medical Center, and Sangeeta Kashyap MD, Assistant Chief of Clinical Affairs at New York-Presbyterian/Weill Cornell Medical Center, discussing how to diagnose and manage NAFLD and NASH in primary care and endocrinology clinical settings. Key topics include screening for NAFLD/NASH, and the latest management recommendations including supplements, medications, bariatric surgery, and more.


Learn how to apply our AACE guideline to your practice by registering for our complimentary course, Managing NAFLD and NASH.

Learn More